Concepedia

Donald W. Everett

DW

Statistics

Publications

11

Citations

904

H-Index

11

Active since

1980

Affiliations

Bristol-Myers Squibb (United States)(Current)

Bristol-Myers Squibb (Germany)

Bristol-Myers Squibb (Sweden)

Donald W. Everett is an author at Bristol-Myers Squibb (United States) specializing in pharmacology, drug metabolism, and pharmacokinetics.

Publications per year

1980–2009

11

Publications

11

IN VITRO INHIBITION OF UDP GLUCURONOSYLTRANSFERASES BY ATAZANAVIR AND OTHER HIV PROTEASE INHIBITORS AND THE RELATIONSHIP OF THIS PROPERTY TO IN VIVO BILIRUBIN GLUCURONIDATION

Donglu Zhang, Theodore J. Chando, Donald W. Everett et al. · Drug Metabolism and Disposition · 2005 · 286 citations

, , +17

Neuroleptic-Induced Decrease in Plasma Homovanillic Acid and Antipsychotic Activity in Schizophrenic Patients

David Pickar, Rodrigo Labarca, Markku Linnoila et al. · Science · 1984 · 245 citations

, , +17

Biotransformation of pravastatin sodium in humans.

Donald W. Everett, Theodore J. Chando, Gerald C. DiDonato et al. · Drug Metabolism and Disposition · 1991 · 112 citations

, , +13

Biotransformation of irbesartan in man.

Theodore J. Chando, Donald W. Everett, A. D. Kahle et al. · PubMed · 1998 · 70 citations

, , +14

Oral Bioavailability and Disposition Characteristics of Irbesartan, an Angiotensin Antagonist, in Healthy Volunteers

Nimish N. Vachharajani, Wen Chyi Shyu, Theodore J. Chando et al. · The Journal of Clinical Pharmacology · 1998 · 48 citations

, , +16

1–5 of 11